Global Brucellosis Vaccines Market Insights and Forecast to 2028

Publisher Name :
Date: 13-Jan-2022
No. of pages: 115
Inquire Before Buying

Brucellosis Vaccines market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Brucellosis Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

- S19 Vaccine

- RB51 Vaccine Strain

Segment by Application

- Cattle

- Sheep

- Others

By Company

- Jinyu

- Colorado Serum

- Boehringer Ingelheim

- Biogenesis-Bago

- Vetal Company

- CZ Veterinaria

- SYVA Laboratorios

- Indian Immunologicals

- Qilu

- Tecnovax

- Hester Biosciences

- Zoetis

- Onderstepoort Biological

- Instituto Rosenbusch

- Ceva Sante Animale

- Calier & Biologicos Laverlam

- Biovet

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - China Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

Global Brucellosis Vaccines Market Insights and Forecast to 2028

Table of Contents
1 Study Coverage
1.1 Brucellosis Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Brucellosis Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 S19 Vaccine
1.2.3 RB51 Vaccine Strain
1.3 Market by Application
1.3.1 Global Brucellosis Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Cattle
1.3.3 Sheep
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Brucellosis Vaccines Sales Estimates and Forecasts 2017-2028
2.2 Global Brucellosis Vaccines Revenue Estimates and Forecasts 2017-2028
2.3 Global Brucellosis Vaccines Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Brucellosis Vaccines Sales by Region
2.4.1 Global Brucellosis Vaccines Sales by Region (2017-2022)
2.4.2 Global Sales Brucellosis Vaccines by Region (2023-2028)
2.5 Global Brucellosis Vaccines Revenue by Region
2.5.1 Global Brucellosis Vaccines Revenue by Region (2017-2022)
2.5.2 Global Brucellosis Vaccines Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Brucellosis Vaccines Sales by Manufacturers
3.1.1 Global Top Brucellosis Vaccines Manufacturers by Sales (2017-2022)
3.1.2 Global Brucellosis Vaccines Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Brucellosis Vaccines in 2021
3.2 Global Brucellosis Vaccines Revenue by Manufacturers
3.2.1 Global Brucellosis Vaccines Revenue by Manufacturers (2017-2022)
3.2.2 Global Brucellosis Vaccines Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Brucellosis Vaccines Revenue in 2021
3.3 Global Brucellosis Vaccines Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Brucellosis Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Brucellosis Vaccines Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Brucellosis Vaccines Sales by Type
4.1.1 Global Brucellosis Vaccines Historical Sales by Type (2017-2022)
4.1.2 Global Brucellosis Vaccines Forecasted Sales by Type (2023-2028)
4.1.3 Global Brucellosis Vaccines Sales Market Share by Type (2017-2028)
4.2 Global Brucellosis Vaccines Revenue by Type
4.2.1 Global Brucellosis Vaccines Historical Revenue by Type (2017-2022)
4.2.2 Global Brucellosis Vaccines Forecasted Revenue by Type (2023-2028)
4.2.3 Global Brucellosis Vaccines Revenue Market Share by Type (2017-2028)
4.3 Global Brucellosis Vaccines Price by Type
4.3.1 Global Brucellosis Vaccines Price by Type (2017-2022)
4.3.2 Global Brucellosis Vaccines Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Brucellosis Vaccines Sales by Application
5.1.1 Global Brucellosis Vaccines Historical Sales by Application (2017-2022)
5.1.2 Global Brucellosis Vaccines Forecasted Sales by Application (2023-2028)
5.1.3 Global Brucellosis Vaccines Sales Market Share by Application (2017-2028)
5.2 Global Brucellosis Vaccines Revenue by Application
5.2.1 Global Brucellosis Vaccines Historical Revenue by Application (2017-2022)
5.2.2 Global Brucellosis Vaccines Forecasted Revenue by Application (2023-2028)
5.2.3 Global Brucellosis Vaccines Revenue Market Share by Application (2017-2028)
5.3 Global Brucellosis Vaccines Price by Application
5.3.1 Global Brucellosis Vaccines Price by Application (2017-2022)
5.3.2 Global Brucellosis Vaccines Price Forecast by Application (2023-2028)
6 North America
6.1 North America Brucellosis Vaccines Market Size by Type
6.1.1 North America Brucellosis Vaccines Sales by Type (2017-2028)
6.1.2 North America Brucellosis Vaccines Revenue by Type (2017-2028)
6.2 North America Brucellosis Vaccines Market Size by Application
6.2.1 North America Brucellosis Vaccines Sales by Application (2017-2028)
6.2.2 North America Brucellosis Vaccines Revenue by Application (2017-2028)
6.3 North America Brucellosis Vaccines Market Size by Country
6.3.1 North America Brucellosis Vaccines Sales by Country (2017-2028)
6.3.2 North America Brucellosis Vaccines Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Brucellosis Vaccines Market Size by Type
7.1.1 Europe Brucellosis Vaccines Sales by Type (2017-2028)
7.1.2 Europe Brucellosis Vaccines Revenue by Type (2017-2028)
7.2 Europe Brucellosis Vaccines Market Size by Application
7.2.1 Europe Brucellosis Vaccines Sales by Application (2017-2028)
7.2.2 Europe Brucellosis Vaccines Revenue by Application (2017-2028)
7.3 Europe Brucellosis Vaccines Market Size by Country
7.3.1 Europe Brucellosis Vaccines Sales by Country (2017-2028)
7.3.2 Europe Brucellosis Vaccines Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Brucellosis Vaccines Market Size by Type
8.1.1 Asia Pacific Brucellosis Vaccines Sales by Type (2017-2028)
8.1.2 Asia Pacific Brucellosis Vaccines Revenue by Type (2017-2028)
8.2 Asia Pacific Brucellosis Vaccines Market Size by Application
8.2.1 Asia Pacific Brucellosis Vaccines Sales by Application (2017-2028)
8.2.2 Asia Pacific Brucellosis Vaccines Revenue by Application (2017-2028)
8.3 Asia Pacific Brucellosis Vaccines Market Size by Region
8.3.1 Asia Pacific Brucellosis Vaccines Sales by Region (2017-2028)
8.3.2 Asia Pacific Brucellosis Vaccines Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Brucellosis Vaccines Market Size by Type
9.1.1 Latin America Brucellosis Vaccines Sales by Type (2017-2028)
9.1.2 Latin America Brucellosis Vaccines Revenue by Type (2017-2028)
9.2 Latin America Brucellosis Vaccines Market Size by Application
9.2.1 Latin America Brucellosis Vaccines Sales by Application (2017-2028)
9.2.2 Latin America Brucellosis Vaccines Revenue by Application (2017-2028)
9.3 Latin America Brucellosis Vaccines Market Size by Country
9.3.1 Latin America Brucellosis Vaccines Sales by Country (2017-2028)
9.3.2 Latin America Brucellosis Vaccines Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Brucellosis Vaccines Market Size by Type
10.1.1 Middle East and Africa Brucellosis Vaccines Sales by Type (2017-2028)
10.1.2 Middle East and Africa Brucellosis Vaccines Revenue by Type (2017-2028)
10.2 Middle East and Africa Brucellosis Vaccines Market Size by Application
10.2.1 Middle East and Africa Brucellosis Vaccines Sales by Application (2017-2028)
10.2.2 Middle East and Africa Brucellosis Vaccines Revenue by Application (2017-2028)
10.3 Middle East and Africa Brucellosis Vaccines Market Size by Country
10.3.1 Middle East and Africa Brucellosis Vaccines Sales by Country (2017-2028)
10.3.2 Middle East and Africa Brucellosis Vaccines Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Jinyu
11.1.1 Jinyu Corporation Information
11.1.2 Jinyu Overview
11.1.3 Jinyu Brucellosis Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Jinyu Brucellosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Jinyu Recent Developments
11.2 Colorado Serum
11.2.1 Colorado Serum Corporation Information
11.2.2 Colorado Serum Overview
11.2.3 Colorado Serum Brucellosis Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Colorado Serum Brucellosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Colorado Serum Recent Developments
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Corporation Information
11.3.2 Boehringer Ingelheim Overview
11.3.3 Boehringer Ingelheim Brucellosis Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Boehringer Ingelheim Brucellosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Boehringer Ingelheim Recent Developments
11.4 Biogenesis-Bago
11.4.1 Biogenesis-Bago Corporation Information
11.4.2 Biogenesis-Bago Overview
11.4.3 Biogenesis-Bago Brucellosis Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Biogenesis-Bago Brucellosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Biogenesis-Bago Recent Developments
11.5 Vetal Company
11.5.1 Vetal Company Corporation Information
11.5.2 Vetal Company Overview
11.5.3 Vetal Company Brucellosis Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Vetal Company Brucellosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Vetal Company Recent Developments
11.6 CZ Veterinaria
11.6.1 CZ Veterinaria Corporation Information
11.6.2 CZ Veterinaria Overview
11.6.3 CZ Veterinaria Brucellosis Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 CZ Veterinaria Brucellosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 CZ Veterinaria Recent Developments
11.7 SYVA Laboratorios
11.7.1 SYVA Laboratorios Corporation Information
11.7.2 SYVA Laboratorios Overview
11.7.3 SYVA Laboratorios Brucellosis Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 SYVA Laboratorios Brucellosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 SYVA Laboratorios Recent Developments
11.8 Indian Immunologicals
11.8.1 Indian Immunologicals Corporation Information
11.8.2 Indian Immunologicals Overview
11.8.3 Indian Immunologicals Brucellosis Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Indian Immunologicals Brucellosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Indian Immunologicals Recent Developments
11.9 Qilu
11.9.1 Qilu Corporation Information
11.9.2 Qilu Overview
11.9.3 Qilu Brucellosis Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Qilu Brucellosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Qilu Recent Developments
11.10 Tecnovax
11.10.1 Tecnovax Corporation Information
11.10.2 Tecnovax Overview
11.10.3 Tecnovax Brucellosis Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Tecnovax Brucellosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Tecnovax Recent Developments
11.11 Hester Biosciences
11.11.1 Hester Biosciences Corporation Information
11.11.2 Hester Biosciences Overview
11.11.3 Hester Biosciences Brucellosis Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Hester Biosciences Brucellosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Hester Biosciences Recent Developments
11.12 Zoetis
11.12.1 Zoetis Corporation Information
11.12.2 Zoetis Overview
11.12.3 Zoetis Brucellosis Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Zoetis Brucellosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Zoetis Recent Developments
11.13 Onderstepoort Biological
11.13.1 Onderstepoort Biological Corporation Information
11.13.2 Onderstepoort Biological Overview
11.13.3 Onderstepoort Biological Brucellosis Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Onderstepoort Biological Brucellosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Onderstepoort Biological Recent Developments
11.14 Instituto Rosenbusch
11.14.1 Instituto Rosenbusch Corporation Information
11.14.2 Instituto Rosenbusch Overview
11.14.3 Instituto Rosenbusch Brucellosis Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Instituto Rosenbusch Brucellosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Instituto Rosenbusch Recent Developments
11.15 Ceva Sante Animale
11.15.1 Ceva Sante Animale Corporation Information
11.15.2 Ceva Sante Animale Overview
11.15.3 Ceva Sante Animale Brucellosis Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Ceva Sante Animale Brucellosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Ceva Sante Animale Recent Developments
11.16 Calier & Biologicos Laverlam
11.16.1 Calier & Biologicos Laverlam Corporation Information
11.16.2 Calier & Biologicos Laverlam Overview
11.16.3 Calier & Biologicos Laverlam Brucellosis Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Calier & Biologicos Laverlam Brucellosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Calier & Biologicos Laverlam Recent Developments
11.17 Biovet
11.17.1 Biovet Corporation Information
11.17.2 Biovet Overview
11.17.3 Biovet Brucellosis Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Biovet Brucellosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Biovet Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Brucellosis Vaccines Industry Chain Analysis
12.2 Brucellosis Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Brucellosis Vaccines Production Mode & Process
12.4 Brucellosis Vaccines Sales and Marketing
12.4.1 Brucellosis Vaccines Sales Channels
12.4.2 Brucellosis Vaccines Distributors
12.5 Brucellosis Vaccines Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Brucellosis Vaccines Industry Trends
13.2 Brucellosis Vaccines Market Drivers
13.3 Brucellosis Vaccines Market Challenges
13.4 Brucellosis Vaccines Market Restraints
14 Key Findings in The Global Brucellosis Vaccines Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Brucellosis Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of S19 Vaccine
Table 3. Major Manufacturers of RB51 Vaccine Strain
Table 4. Global Brucellosis Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Brucellosis Vaccines Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Brucellosis Vaccines Sales by Region (2017-2022) & (M Doses)
Table 7. Global Brucellosis Vaccines Sales Market Share by Region (2017-2022)
Table 8. Global Brucellosis Vaccines Sales by Region (2023-2028) & (M Doses)
Table 9. Global Brucellosis Vaccines Sales Market Share by Region (2023-2028)
Table 10. Global Brucellosis Vaccines Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Brucellosis Vaccines Revenue Market Share by Region (2017-2022)
Table 12. Global Brucellosis Vaccines Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Brucellosis Vaccines Revenue Market Share by Region (2023-2028)
Table 14. Global Brucellosis Vaccines Sales by Manufacturers (2017-2022) & (M Doses)
Table 15. Global Brucellosis Vaccines Sales Share by Manufacturers (2017-2022)
Table 16. Global Brucellosis Vaccines Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Brucellosis Vaccines Revenue Share by Manufacturers (2017-2022)
Table 18. Brucellosis Vaccines Price by Manufacturers (2017-2022) &(USD/K Doses)
Table 19. Global Brucellosis Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Brucellosis Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brucellosis Vaccines as of 2021)
Table 21. Brucellosis Vaccines Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Brucellosis Vaccines Product Offered
Table 23. Date of Manufacturers Enter into Brucellosis Vaccines Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Brucellosis Vaccines Sales by Type (2017-2022) & (M Doses)
Table 26. Global Brucellosis Vaccines Sales by Type (2023-2028) & (M Doses)
Table 27. Global Brucellosis Vaccines Sales Share by Type (2017-2022)
Table 28. Global Brucellosis Vaccines Sales Share by Type (2023-2028)
Table 29. Global Brucellosis Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Brucellosis Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Brucellosis Vaccines Revenue Share by Type (2017-2022)
Table 32. Global Brucellosis Vaccines Revenue Share by Type (2023-2028)
Table 33. Brucellosis Vaccines Price by Type (2017-2022) & (USD/K Doses)
Table 34. Global Brucellosis Vaccines Price Forecast by Type (2023-2028) & (USD/K Doses)
Table 35. Global Brucellosis Vaccines Sales by Application (2017-2022) & (M Doses)
Table 36. Global Brucellosis Vaccines Sales by Application (2023-2028) & (M Doses)
Table 37. Global Brucellosis Vaccines Sales Share by Application (2017-2022)
Table 38. Global Brucellosis Vaccines Sales Share by Application (2023-2028)
Table 39. Global Brucellosis Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Brucellosis Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Brucellosis Vaccines Revenue Share by Application (2017-2022)
Table 42. Global Brucellosis Vaccines Revenue Share by Application (2023-2028)
Table 43. Brucellosis Vaccines Price by Application (2017-2022) & (USD/K Doses)
Table 44. Global Brucellosis Vaccines Price Forecast by Application (2023-2028) & (USD/K Doses)
Table 45. North America Brucellosis Vaccines Sales by Type (2017-2022) & (M Doses)
Table 46. North America Brucellosis Vaccines Sales by Type (2023-2028) & (M Doses)
Table 47. North America Brucellosis Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Brucellosis Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Brucellosis Vaccines Sales by Application (2017-2022) & (M Doses)
Table 50. North America Brucellosis Vaccines Sales by Application (2023-2028) & (M Doses)
Table 51. North America Brucellosis Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Brucellosis Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Brucellosis Vaccines Sales by Country (2017-2022) & (M Doses)
Table 54. North America Brucellosis Vaccines Sales by Country (2023-2028) & (M Doses)
Table 55. North America Brucellosis Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Brucellosis Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Brucellosis Vaccines Sales by Type (2017-2022) & (M Doses)
Table 58. Europe Brucellosis Vaccines Sales by Type (2023-2028) & (M Doses)
Table 59. Europe Brucellosis Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Brucellosis Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Brucellosis Vaccines Sales by Application (2017-2022) & (M Doses)
Table 62. Europe Brucellosis Vaccines Sales by Application (2023-2028) & (M Doses)
Table 63. Europe Brucellosis Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Brucellosis Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Brucellosis Vaccines Sales by Country (2017-2022) & (M Doses)
Table 66. Europe Brucellosis Vaccines Sales by Country (2023-2028) & (M Doses)
Table 67. Europe Brucellosis Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Brucellosis Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Brucellosis Vaccines Sales by Type (2017-2022) & (M Doses)
Table 70. Asia Pacific Brucellosis Vaccines Sales by Type (2023-2028) & (M Doses)
Table 71. Asia Pacific Brucellosis Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Brucellosis Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Brucellosis Vaccines Sales by Application (2017-2022) & (M Doses)
Table 74. Asia Pacific Brucellosis Vaccines Sales by Application (2023-2028) & (M Doses)
Table 75. Asia Pacific Brucellosis Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Brucellosis Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Brucellosis Vaccines Sales by Region (2017-2022) & (M Doses)
Table 78. Asia Pacific Brucellosis Vaccines Sales by Region (2023-2028) & (M Doses)
Table 79. Asia Pacific Brucellosis Vaccines Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Brucellosis Vaccines Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Brucellosis Vaccines Sales by Type (2017-2022) & (M Doses)
Table 82. Latin America Brucellosis Vaccines Sales by Type (2023-2028) & (M Doses)
Table 83. Latin America Brucellosis Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Brucellosis Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Brucellosis Vaccines Sales by Application (2017-2022) & (M Doses)
Table 86. Latin America Brucellosis Vaccines Sales by Application (2023-2028) & (M Doses)
Table 87. Latin America Brucellosis Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Brucellosis Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Brucellosis Vaccines Sales by Country (2017-2022) & (M Doses)
Table 90. Latin America Brucellosis Vaccines Sales by Country (2023-2028) & (M Doses)
Table 91. Latin America Brucellosis Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Brucellosis Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Brucellosis Vaccines Sales by Type (2017-2022) & (M Doses)
Table 94. Middle East and Africa Brucellosis Vaccines Sales by Type (2023-2028) & (M Doses)
Table 95. Middle East and Africa Brucellosis Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Brucellosis Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Brucellosis Vaccines Sales by Application (2017-2022) & (M Doses)
Table 98. Middle East and Africa Brucellosis Vaccines Sales by Application (2023-2028) & (M Doses)
Table 99. Middle East and Africa Brucellosis Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Brucellosis Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Brucellosis Vaccines Sales by Country (2017-2022) & (M Doses)
Table 102. Middle East and Africa Brucellosis Vaccines Sales by Country (2023-2028) & (M Doses)
Table 103. Middle East and Africa Brucellosis Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Brucellosis Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 105. Jinyu Corporation Information
Table 106. Jinyu Description and Major Businesses
Table 107. Jinyu Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 108. Jinyu Brucellosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Jinyu Recent Developments
Table 110. Colorado Serum Corporation Information
Table 111. Colorado Serum Description and Major Businesses
Table 112. Colorado Serum Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 113. Colorado Serum Brucellosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Colorado Serum Recent Developments
Table 115. Boehringer Ingelheim Corporation Information
Table 116. Boehringer Ingelheim Description and Major Businesses
Table 117. Boehringer Ingelheim Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 118. Boehringer Ingelheim Brucellosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Boehringer Ingelheim Recent Developments
Table 120. Biogenesis-Bago Corporation Information
Table 121. Biogenesis-Bago Description and Major Businesses
Table 122. Biogenesis-Bago Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 123. Biogenesis-Bago Brucellosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Biogenesis-Bago Recent Developments
Table 125. Vetal Company Corporation Information
Table 126. Vetal Company Description and Major Businesses
Table 127. Vetal Company Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 128. Vetal Company Brucellosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Vetal Company Recent Developments
Table 130. CZ Veterinaria Corporation Information
Table 131. CZ Veterinaria Description and Major Businesses
Table 132. CZ Veterinaria Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 133. CZ Veterinaria Brucellosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. CZ Veterinaria Recent Developments
Table 135. SYVA Laboratorios Corporation Information
Table 136. SYVA Laboratorios Description and Major Businesses
Table 137. SYVA Laboratorios Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 138. SYVA Laboratorios Brucellosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. SYVA Laboratorios Recent Developments
Table 140. Indian Immunologicals Corporation Information
Table 141. Indian Immunologicals Description and Major Businesses
Table 142. Indian Immunologicals Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 143. Indian Immunologicals Brucellosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Indian Immunologicals Recent Developments
Table 145. Qilu Corporation Information
Table 146. Qilu Description and Major Businesses
Table 147. Qilu Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 148. Qilu Brucellosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Qilu Recent Developments
Table 150. Tecnovax Corporation Information
Table 151. Tecnovax Description and Major Businesses
Table 152. Tecnovax Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 153. Tecnovax Brucellosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Tecnovax Recent Developments
Table 155. Hester Biosciences Corporation Information
Table 156. Hester Biosciences Description and Major Businesses
Table 157. Hester Biosciences Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 158. Hester Biosciences Brucellosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Hester Biosciences Recent Developments
Table 160. Zoetis Corporation Information
Table 161. Zoetis Description and Major Businesses
Table 162. Zoetis Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 163. Zoetis Brucellosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. Zoetis Recent Developments
Table 165. Onderstepoort Biological Corporation Information
Table 166. Onderstepoort Biological Description and Major Businesses
Table 167. Onderstepoort Biological Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 168. Onderstepoort Biological Brucellosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 169. Onderstepoort Biological Recent Developments
Table 170. Instituto Rosenbusch Corporation Information
Table 171. Instituto Rosenbusch Description and Major Businesses
Table 172. Instituto Rosenbusch Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 173. Instituto Rosenbusch Brucellosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 174. Instituto Rosenbusch Recent Developments
Table 175. Ceva Sante Animale Corporation Information
Table 176. Ceva Sante Animale Description and Major Businesses
Table 177. Ceva Sante Animale Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 178. Ceva Sante Animale Brucellosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 179. Ceva Sante Animale Recent Developments
Table 180. Calier & Biologicos Laverlam Corporation Information
Table 181. Calier & Biologicos Laverlam Description and Major Businesses
Table 182. Calier & Biologicos Laverlam Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 183. Calier & Biologicos Laverlam Brucellosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 184. Calier & Biologicos Laverlam Recent Developments
Table 185. Biovet Corporation Information
Table 186. Biovet Description and Major Businesses
Table 187. Biovet Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 188. Biovet Brucellosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 189. Biovet Recent Developments
Table 190. Key Raw Materials Lists
Table 191. Raw Materials Key Suppliers L
  • Global and United States Eye Allergy Therapeutics Market Report & Forecast 2022-2028
    Published: 17-May-2022        Price: US 4350 Onwards        Pages: 95
    Eye Allergy Therapeutics market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Eye Allergy Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028. For United States market, this report focuses on the Eye Allergy Therapeutics market s......
  • Global and United States Radiodermatitis Treatment Market Report & Forecast 2022-2028
    Published: 17-May-2022        Price: US 4350 Onwards        Pages: 96
    Radiodermatitis Treatment market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Radiodermatitis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028. For United States market, this report focuses on the Radiodermatitis Treatment marke......
  • Global and United States DXM and Codeine Syrup Market Report & Forecast 2022-2028
    Published: 17-May-2022        Price: US 4350 Onwards        Pages: 90
    DXM and Codeine Syrup market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global DXM and Codeine Syrup market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028. For United States market, this report focuses on the DXM and Codeine Syrup market size by pl......
  • Global and United States Cough and Cold Medicine Market Report & Forecast 2022-2028
    Published: 17-May-2022        Price: US 4350 Onwards        Pages: 92
    Cough and Cold Medicine market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Cough and Cold Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028. For United States market, this report focuses on the Cough and Cold Medicine market size......
  • Global and United States Cough Drops Market Report & Forecast 2022-2028
    Published: 17-May-2022        Price: US 4350 Onwards        Pages: 97
    Cough Drops market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Cough Drops market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028. For United States market, this report focuses on the Cough Drops market size by players, by Type and by Applicat......
  • Global and United States Expectorants Market Report & Forecast 2022-2028
    Published: 17-May-2022        Price: US 4350 Onwards        Pages: 91
    Expectorants market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Expectorants market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028. For United States market, this report focuses on the Expectorants market size by players, by Type and by Appli......
  • Global and United States Cough Suppressants Market Report & Forecast 2022-2028
    Published: 17-May-2022        Price: US 4350 Onwards        Pages: 92
    Cough Suppressants market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Cough Suppressants market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028. For United States market, this report focuses on the Cough Suppressants market size by players, by......
  • Global and United States Cough Syrup Market Report & Forecast 2022-2028
    Published: 17-May-2022        Price: US 4350 Onwards        Pages: 90
    Cough Syrup market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Cough Syrup market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028. For United States market, this report focuses on the Cough Syrup market size by players, by Type and by Applicat......
  • Global and United States Topical Analgesics Market Report & Forecast 2022-2028
    Published: 17-May-2022        Price: US 4350 Onwards        Pages: 114
    Topical Analgesics market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Topical Analgesics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028. For United States market, this report focuses on the Topical Analgesics market size by players, by......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs